Want to see LPCN full AI Analyst Report?
Total Valuation
Lipocine has a market cap or net worth of $20.36M. The enterprise value is $8.56M.
Market Cap$20.36M
Enterprise Value$8.56M
Share Statistics
Lipocine has 8,244,253 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding8,244,253
Owned by Insiders4.61%
Owned by Institutions28.41%
Financial Efficiency
Lipocine’s return on equity (ROE) is -0.67 and return on invested capital (ROIC) is -71.64%.
Return on Equity (ROE)-0.67
Return on Assets (ROA)-0.57
Return on Invested Capital (ROIC)-71.64%
Return on Capital Employed (ROCE)-0.72
Revenue Per Employee123.54K
Profits Per Employee-601.72K
Employee Count16
Asset Turnover0.12
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Lipocine is ―. Lipocine’s PEG ratio is 0.00004.
PE Ratio―
PS Ratio22.14
PB Ratio3.02
Price to Fair Value3.02
Price to FCF-4.48
Price to Operating Cash Flow-1.63
PEG Ratio0.00004
Income Statement
In the last 12 months, Lipocine had revenue of 1.98M and earned -9.63M in profits. Earnings per share was -1.77.
Revenue1.98M
Gross Profit-6.61M
Operating Income-10.37M
Pretax Income-9.63M
Net Income-9.63M
EBITDA-9.57M
Earnings Per Share (EPS)-1.77
Cash Flow
In the last 12 months, operating cash flow was -10.05M and capital expenditures 1.00, giving a free cash flow of -10.05M billion.
Operating Cash Flow-10.05M
Free Cash Flow-10.05M
Free Cash Flow per Share-1.22
Dividends & Yields
Lipocine pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.45
52-Week Price Change-24.69%
50-Day Moving Average2.31
200-Day Moving Average4.65
Relative Strength Index (RSI)49.82
Average Volume (3m)93.44K
Important Dates
Lipocine upcoming earnings date is Aug 6, 2026, Before Open (Confirmed).
Last Earnings DateMay 7, 2026
Next Earnings DateAug 6, 2026
Ex-Dividend Date―
Financial Position
Lipocine as a current ratio of 6.68, with Debt / Equity ratio of 0.00%
Current Ratio6.68
Quick Ratio6.68
Debt to Market Cap0.00
Net Debt to EBITDA0.54
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Lipocine has paid 200.00 in taxes.
Income Tax200.00
Effective Tax Rate>-0.01
Enterprise Valuation
Lipocine EV to EBITDA ratio is -4.03, with an EV/FCF ratio of -3.95.
EV to Sales19.50
EV to EBITDA-4.03
EV to Free Cash Flow-3.95
EV to Operating Cash Flow-3.95
Balance Sheet
Lipocine has $24.73M in cash and marketable securities with $0.00 in debt, giving a net cash position of $24.73M billion.
Cash & Marketable Securities$24.73M
Total Debt$0.00
Net Cash$24.73M
Net Cash Per Share$3.00
Tangible Book Value Per Share$2.66
Margins
Gross margin is -8.21%, with operating margin of -524.69%, and net profit margin of -487.06%.
Gross Margin-8.21%
Operating Margin-524.69%
Pretax Margin-487.04%
Net Profit Margin-487.06%
EBITDA Margin-483.97%
EBIT Margin-487.04%
Analyst Forecast
The average price target for Lipocine is $6.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$6.00
Price Target Upside105.48% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast-45.52%
EPS Growth Forecast-94.82%